The conversation continues at BioNJ’s C-Suite Summit with the “Evolving Policy Landscape & Strategic Implications for Innovation Leaders” panel. Rachel Licata, Bristol Myers Squibb, and Jennifer Walton, Pfizer, are sharing perspectives on policy, pricing, regulatory priorities and their impact on innovation. Moderated by Emilio Ragosa, DLA Piper.
#BioNJCsuite #LifeSciences #Biopharma #HealthcarePolicy #Innovation #NewJersey
Thank you to the 2025 @acscan Houston Research and Health Equity Breakfast event partners! Your support makes this event possible, and we are grateful for your partnership in the fight against cancer. #CancerResearch
Check out this interview with IowaBio Executive Director Jessica Hyland and PowerPollen Senior Advisor Kavi Chawla as they discuss this exciting news! #IowaBio#PowerPollen#AgNews#IndiaTradeMission#Iowa
https://t.co/ZOFEbL6Dmp
Cancer impacts so many families across the country. I met with @ACSCAN advocates from Iowa to hear their stories. In Congress, I’m fighting for legislation to advance cancer research and improve patient care.
Thank you, @RepMMM and her staff member Blake for a great meeting with our Iowa volunteer team and thank you for being a co-sponsor of the Medicare Multi-Cancer Early Detection Screening Coverage Act! #CancerLobbyDay
Team Iowa dedicated time during their lawmaker meetings to engage with the media on Capitol Hill. Check out their impressive efforts to highlight critical cancer issues aimed at reducing the burden of cancer for everyone. #CancerLobbyDay https://t.co/FDVIsKss75
The Field Government Relations Professional of the Year Award goes to Emily Kalmer for her outstanding contributions made on behalf of cancer policy in Missouri. Her lobbying work helped stop bad tobacco bills and advance access to care issues to improve lives. #CancerLobbyDay
Thanks to everyone who came out to our BioCafe at the Austin Club yesterday! We had a great discussion about the drug development process. And thanks to our partners and sponsors @TXManufacturers, @bmsnews, @ucb_news, @CSLBehring.
“Today is an important win for cancer survivors and patients across Iowa,” said Maria Steele, volunteer with @ACSCANIowa. “I am thrilled more Iowans will have access to targeted therapies like the ones I was fortunate enough to have. They greatly improved my quality of life.”
A BIG day indeed! Thank you to @IAGovernor Reynolds for signing this important legislation into law, allowing more cancer patients to get the biomarker testing they need to get the right treatment at the right time! And great work @ACSCANIowa team! #IAleg
Incredible news out of Des Moines today: With @IAGovernor Reynolds’ signature, Iowa is now the 16th state to enact @ACSCAN-supported legislation to expand access to biomarker testing. This is a huge win for cancer patients!
We did it! Biomarker testing has passed the full House! The bill is on its way to Governor Reynolds’ desk. Thank you to all our volunteers for helping make biomarker testing more accessible for the people who need it. This legislation will truly impact so many Iowans.
Maria Steele, ACS CAN volunteer, bravely shared her biomarker testing story with us and advocated to lawmakers asking them to pass the biomarker testing bill. We are so grateful for volunteers like Maria who are willing to share their stories to create positive change for all.
For bio industry in N.J., a celebration — and a call to change narrative. Leader, on the industry’s biggest night, offer personal stories of success – and the importance of sharing them with a skeptical and cynical public.
https://t.co/XCrZAp2xI0
Thank you, @KCCINews, Ethan Humble and @_JodiLong_ for sharing Maria's story! Cancer advocates with @acscaniowa are asking #IAleg to pass legislation that expands access to biomarker testing. https://t.co/DC9Va8401l